Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Study results revealed in Europe last week cast doubt on the efficacy of renal denervation for treating high blood pressure.
2. CareFusion may be weighing 2 very different deals
CareFusion seems to be a key potential acquirer for at least 2 medical device businesses known to be on the block – ICU Medical and Smiths Group’s Smiths Medical.
A pair of independent analyses of patient-level data commissioned by a Yale University open data program show that Medtronic’s Infuse bone-growth putty is equivalent to bone grafts, with 1 concluding that early Infuse research was biased.